SEARCH

SEARCH BY CITATION

REFERENCES

  • Abdenur JE, Abeling N, Specola N, Jorge L, Schenone AB, van Cruchten AC, Chamoles NA. 2006. Aromatic L-amino acid decarboxylase deficiency: unusual neonatal presentation and additional findings in organic acid analysis. Mol Genet Metab 87:4853.
  • Aksoy IA, Weinshilboum RM. 1995. Human thermolabile phenol sulfotransferase gene (STM): molecular cloning and structural characterization. Biochem Biophys Res Commun 208:786795.
  • Albert VR, Lee MR, Bolden AH, Wurzburger RJ, Aguanno A. 1992. Distinct promoters direct neuronal and nonneuronal expression of rat aromatic l-amino acid decarboxylase. Proc Natl Acad Sci USA 89:1205312057.
  • Aneman A, Eisenhofer G, Fandriks L, Friberg P. 1995. Hepatomesenteric release and removal of norepinephrine in swine. Am J Physiol 268(Pt 2):R924R930.
  • Asberg M, Traskman L, Thoren P. 1976. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 33:11931197.
  • Bertoldi M, Borri Voltattorni C. 2003. Reaction and substrate specificity of recombinant pig kidney Dopa decarboxylase under aerobic and anaerobic conditions. Biochim Biophys Acta 1647:4247.
  • Biaggioni I, Robertson D. 1987. Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2:11701172.
  • Biederman J, Faraone SV. 2005. Attention-deficit hyperactivity disorder. Lancet 366:237248.
  • Borglum AD, Bruun TG, Kjeldsen TE, Ewald H, Mors O, Kirov G, Russ C, Freeman B, Collier DA, Kruse TA. 1999. Two novel variants in the DOPA decarboxylase gene: association with bipolar affective disorder. Mol Psychiatry 4:545551.
  • Brautigam C, Steenbergen-Spanjers GC, Hoffmann GF, Dionisi-Vici C, van den Heuvel LP, Smeitink JA, Wevers RA. 1999. Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency. Clin Chem 45:20732078.
  • Brummett BH, Krystal AD, Siegler IC, Kuhn C, Surwit RS, Zuchner S, Ashley-Koch A, Barefoot JC, Williams RB. 2007. Associations of a regulatory polymorphism of monoamine oxidase-A gene promoter (MAOA-uVNTR) with symptoms of depression and sleep quality. Psychosom Med 69:396401.
  • Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. 1993. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262:578580.
  • Buervenich S, Carmine A, Galter D, Shahabi HN, Johnels B, Holmberg B, Ahlberg J, Nissbrandt H, Eerola J, Hellstrom O, Tienari PJ, Matsuura T, Ashizawa T, Wüllner U, Klockgether T, Zimprich A, Gasser T, Hanson M, Waseem S, Singleton A, McMahon FJ, Anvret M, Sydow O, Olson L. 2005. A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample. Arch Neurol 62:7478.
  • Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, Malhotra AK. 2007. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord 9:370376.
  • Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Muller U, Aguet M, Babinet C, Shih JC, De Maeyer E. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268:17631766.
  • Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. 2002. Role of genotype in the cycle of violence in maltreated children. Science 297:851854.
  • Chang YT, Mues G, McPherson JD, Bedell JA, Marsh JL, Hyland K. 1998. Mutations in the human aromatic l-amino acid decarboxylase gene. J Inherit Metab Dis 21(Suppl 2):4.
  • Chang YT, Sharma R, Marsh JL, McPherson JD, Bedell JA, Knust A, Brautigam C, Hoffmann GF, Hyland K. 2004. Levodopa-responsive aromatic l-amino acid decarboxylase deficiency. Ann Neurol 55:435438.
  • Christenson JG, Dairman W, Udenfriend S. 1972. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic l-amino acid decarboxylase-serotonin-dopamine-norepinephrine). Proc Natl Acad Sci USA 69:343347.
  • Cichon S, Winge I, Mattheisen M, Georgi A, Karpushova A, Freudenberg J, Freudenberg-Hua Y, Babadjanova G, Van Den Bogaert A, Abramova LI, Kapiletti S, Knappskog PM, McKinney J, Maier W, Jamra RA, Schulze TG, Schumacher J, Propping P, Rieschel M, Haavik J, Nöthen MM. 2008. Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5′-region are associated with bipolar affective disorder. Hum Mol Genet 17:8797.
  • D'Souza UM, Craig IW. 2006. Functional polymorphisms in dopamine and serotonin pathway genes. Hum Mutat 27:113.
  • De Lonlay P, Nassogne MC, van Gennip AH, van Cruchten AC, Billatte de Villemeur T, Cretz M, Stoll C, Launay JM, Steenberger-Spante GC, van den Heuvel LP, Wevers RA, Saudubray JM, Abeling NG. 2000. Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation. J Inherit Metab Dis 23:819825.
  • de Rijk-Van Andel JF, Gabreels FJ, Geurtz B, Steenbergen-Spanjers GC, van Den Heuvel LP, Smeitink JA, Wevers RA. 2000. l-dopa-responsive infantile hypokinetic rigid parkinsonism due to tyrosine hydroxylase deficiency. Neurology 55:19261928.
  • Deinum J, Steenbergen-Spanjers GC, Jansen M, Boomsma F, Lenders JW, van Ittersum FJ, Huck N, van den Heuvel LP, Wevers RA. 2004. DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome. J Med Genet 41:e38.
  • Dhondt, J-L. 2006. Laboratory diagnosis of phenylketonuria. In: BlauN, editor. PKU and BH4: advances in phenylketonuria and tetrahydrobiopterion. Heilbronn: SPS Verlagsgesellschaft. p 161179.
  • Diepold K, Schutz B, Rostasy K, Wilken B, Hougaard P, Guttler F, Romstad A, Birk Moller L. 2005. Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections. Mov Disord 20:764767.
  • Ebert SN, Rong Q, Boe S, Thompson RP, Grinberg A, Pfeifer K. 2004. Targeted insertion of the Cre-recombinase gene at the phenylethanolamine n-methyltransferase locus: a new model for studying the developmental distribution of adrenergic cells. Dev Dyn 231:849858.
  • Eisenhofer G, Aneman A, Hooper D, Holmes C, Goldstein DS, Friberg P. 1995. Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine. Am J Physiol 268(Pt 1):G641G649.
  • Eisenhofer G, Aneman A, Friberg P, Hooper D, Fandriks L, Lonroth H, Hunyady B, Mezey E. 1997. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 82:38643871.
  • Eisenhofer G, Coughtrie MW, Goldstein DS. 1999. Dopamine sulphate: an enigma resolved. Clin Exp Pharmacol Physiol Suppl 26:S41S53.
  • Eisenhofer G, Kopin IJ, Goldstein DS. 2004. Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331349.
  • Eisenhofer G, Huysmans F, Pacak K, Walther MM, Sweep FC, Lenders JW. 2005. Plasma metanephrines in renal failure. Kidney Int 67:668677.
  • Embden G, Baldes K. 1913. Über den Abbau des Phenylalanins im tierischen Organismus (on the degradation of phenylalanine in animal organisms). Biochem Z 55:301322.
  • Fitzpatrick PF. 2000. The aromatic amino acid hydroxylases. Adv Enzymol Relat Areas Mol Biol 74:235294.
  • Fiumara A, Brautigam C, Hyland K, Sharma R, Lagae L, Stoltenborg B, Hoffmann GF, Jaeken J, Wevers RA. 2002. Aromatic l-amino acid decarboxylase deficiency with hyperdopaminuria. Clinical and laboratory findings in response to different therapies. Neuropediatrics 33:203208.
  • Frazzetto G, Di Lorenzo G, Carola V, Proietti L, Sokolowska E, Siracusano A, Gross C, Troisi A. 2007. Early trauma and increased risk for physical aggression during adulthood: the moderating role of MAOA genotype. PLoS ONE 2:e486.
  • Fresan A, Camarena B, Apiquian R, Aguilar A, Urraca N, Nicolini H. 2007. Association study of MAO-A and DRD4 genes in schizophrenic patients with aggressive behavior. Neuropsychobiology 55:171175.
  • Furukawa Y, Graf WD, Wong H, Shimadzu M, Kish SJ. 2001. Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology 56:260263.
  • Gershon MD. 2003. Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol 3:600607.
  • Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M. 1998. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 95:99919996.
  • Goldstein DS. 1995. Stress, catecholamines, and cardiovascular disease. New York: Oxford University Press.
  • Goldstein DS, Lenders JW, Kaler SG, Eisenhofer G. 1996. Catecholamine phenotyping: clues to the diagnosis, treatment, and pathophysiology of neurogenetic disorders. J Neurochem 67:17811790.
  • Grahame-Smith DG. 1964. Tryptophan hydroxylation in brain. Biochem Biophys Res Commun 16:586592.
  • Grattan-Smith PJ, Wevers RA, Steenbergen-Spanjers GC, Fung VS, Earl J, Wilcken B. 2002. Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy. Mov Disord 17:354359.
  • Grima B, Lamouroux A, Boni C, Julien JF, Javoy-Agid F, Mallet J. 1987. A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 326:707711.
  • Harvey M, Shink E, Tremblay M, Gagne B, Raymond C, Labbe M, Walther DJ, Bader M, Barden N. 2004. Support for the involvement of TPH2 gene in affective disorders. Mol Psychiatry 9:980981.
  • Hilbert P, Lindpaintner K, Beckmann JS, Serikawa T, Soubrier F, Dubay C, Cartwright P, De Gouyon B, Julier C, Takahasi S, Vincent M, Ganten D, Georges M, Lathrop GM. 1991. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 353:521529.
  • Hildebrandt MA, Salavaggione OE, Martin YN, Flynn HC, Jalal S, Wieben ED, Weinshilboum RM. 2004. Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. Biochem Biophys Res Commun 321:870878.
  • Hoffmann GF, Assmann B, Brautigam C, Dionisi-Vici C, Haussler M, de Klerk JB, Naumann M, Steenbergen-Spanjers GC, Strassburg HM, Wevers RA. 2003. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol 54(Suppl 6):S56S65.
  • Hotamisligil GS, Breakefield XO. 1991. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 49:383392.
  • Huang SY, Lin WW, Wan FJ, Chang AJ, Ko HC, Wang TJ, Wu PL, Lu RB. 2007. Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci 32:185192.
  • Hyland K, Clayton PT. 1992. Aromatic l-amino acid decarboxylase deficiency: diagnostic methodology. Clin Chem 38:24052410.
  • Hyland K, Surtees RA, Rodeck C, Clayton PT. 1992. Aromatic l-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology 42:19801988.
  • Hyland K. 2005. Disorders of neurotransmitter metabolism. In: BlauN, DuranM, BlaskovicsME, GibsonKM, editors. Physician's guide to the laboratory diagnosis of metabolic diseases. 2nd edition. Berlin: Springer Verlag. p 106122.
  • Ichinose H, Kurosawa Y, Titani K, Fujita K, Nagatsu T. 1989. Isolation and characterization of a cDNA clone encoding human aromatic L-amino acid decarboxylase. Biochem Biophys Res Commun 164:10241030.
  • Ichinose H, Ohye T, Takahashi E, Seki N, Hori T, Segawa M, Nomura Y, Endo K, Tanaka H, Tsuji S, Fujita K, Nagatsu T. 1994. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat Genet 8:236242.
  • Ishiguro H, Arinami T, Saito T, Akazawa S, Enomoto M, Mitushio H, Fujishiro H, Tada K, Akimoto Y, Mifune H, Shiozuka S, Hamaguchi H, Toru M, Shibuya H. 1998. Systematic search for variations in the tyrosine hydroxylase gene and their associations with schizophrenia, affective disorders, and alcoholism. Am J Med Genet 81:388396.
  • Jacob HJ, Lindpaintner K, Lincoln SE, Kusumi K, Bunker RK, Mao YP, Ganten D, Dzau VJ, Lander ES. 1991. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 67:213224.
  • Janssen RJ, Wevers RA, Haussler M, Luyten JA, Steenbergen-Spanjers GC, Hoffmann GF, Nagatsu T, Van den Heuvel LP. 2000. A branch site mutation leading to aberrant splicing of the human tyrosine hydroxylase gene in a child with a severe extrapyramidal movement disorder. Ann Hum Genet 64(Pt 5):375382.
  • Ji Y, Salavaggione OE, Wang L, Adjei AA, Eckloff B, Wieben ED, Weinshilboum RM. 2005. Human phenylethanolamine N-methyltransferase pharmacogenomics: gene re-sequencing and functional genomics. J Neurochem 95:17661776.
  • Julier C, Delepine M, Keavney B, Terwilliger J, Davis S, Weeks DE, Bui T, Jeunemaitre X, Velho G, Froguel P, Ratcliffe P, Corvol P, Soubrier F, Lathrop GM. 1997. Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet 6:20772085.
  • Kaler SG, Goldstein DS, Holmes C, Salerno JA, Gahl WA. 1993. Plasma and cerebrospinal fluid neurochemical pattern in Menkes disease. Ann Neurol 33:171175.
  • Kaneda N, Kobayashi K, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T. 1987. Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem Biophys Res Commun 146:971975.
  • Kepp K, Juhanson P, Kozich V, Ots M, Viigimaa M, Laan M. 2007. Resequencing PNMT in European hypertensive and normotensive individuals: no common susceptibility variants for hypertension and purifying selection on intron 1. BMC Med Genet 8:47.
  • Kim CH, Zabetian CP, Cubells JF, Cho S, Biaggioni I, Cohen BM, Robertson D, Kim KS. 2002. Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet 108:140147.
  • Knappskog PM, Flatmark T, Mallet J, Ludecke B, Bartholome K. 1995. Recessively inherited l-DOPA-responsive dystonia caused by a point mutation (Q381 K) in the tyrosine hydroxylase gene. Hum Mol Genet 4:12091212.
  • Kobayashi K, Kurosawa Y, Fujita K, Nagatsu T. 1989. Human dopamine beta-hydroxylase gene: two mRNA types having different 3′-terminal regions are produced through alternative polyadenylation. Nucleic Acids Res 17:10891102.
  • Kopeckova M, Paclt I, Goetz P. 2006. Polymorphisms and low plasma activity of dopamine-beta-hydroxylase in ADHD children. Neuro Endocrinol Lett 27:748754.
  • Korenke GC, Christen HJ, Hyland K, Hunneman DH, Hanefeld F. 1997. Aromatic l-amino acid decarboxylase deficiency: an extrapyramidal movement disorder with oculogyric crises. Eur J Paediatr Neurol 1:6771.
  • Krieger M, Coge F, Gros F, Thibault J. 1991. Different mRNAs code for dopa decarboxylase in tissues of neuronal and nonneuronal origin. Proc Natl Acad Sci USA 88:21612165.
  • Lee SG, Joo Y, Kim B, Chung S, Kim HL, Lee I, Choi B, Kim C, Song K. 2005. Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum Genet 116:319328.
  • Lenders JW, Eisenhofer G, Abeling NG, Berger W, Murphy DL, Konings CH, Wagemakers LM, Kopin IJ, Karoum F, van Gennip AH, Brunner HG. 1996. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J Clin Invest 97:10101019.
  • Lovenberg W, Weissbach H, Udenfriend S. 1962. Aromatic l-amino acid decarboxylase. J Biol Chem 237:8993.
  • Lucki I. 1998. The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44:151162.
  • Ludecke B, Bartholome K. 1995. Frequent sequence variant in the human tyrosine hydroxylase gene. Hum Genet 95:716.
  • Ludecke B, Dworniczak B, Bartholome K. 1995. A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum Genet 95:123125.
  • Ludecke B, Knappskog PM, Clayton PT, Surtees RA, Clelland JD, Heales SJ, Brand MP, Bartholome K, Flatmark T. 1996. Recessively inherited l-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet 5:10231028.
  • Lundström K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Ulmanen I. 1995. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta 1251:110.
  • Mallet J. 1999. Tyrosine hydroxylase from cloning to neuropsychiatric disorders. Brain Res Bull 50:381382.
  • Man in 't Veld AJ, Boomsma F, Moleman P, Schalekamp MA. 1987. Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome. Lancet 1:183188.
  • Mann MB, Wu S, Rostamkhani M, Tourtellotte W, MacMurray J, Comings DE. 2001. Phenylethanolamine N-methyltransferase (PNMT) gene and early-onset Alzheimer disease. Am J Med Genet 105:312316.
  • Mannisto PT, Kaakkola S. 1999. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593628.
  • McKinney J, Knappskog PM, Haavik J. 2005. Different properties of the central and peripheral forms of human tryptophan hydroxylase. J Neurochem 92:311320.
  • Mezey E, Eisenhofer G, Hansson S, Harta G, Hoffman BJ, Gallatz K, Palkovits M, Hunyady B. 1999. Non-neuronal dopamine in the gastrointestinal system. Clin Exp Pharmacol Physiol Suppl 26:S14S22.
  • Moller LB, Romstad A, Paulsen M, Hougaard P, Ormazabal A, Pineda M, Blau N, Guttler F, Artuch R. 2005. Pre- and postnatal diagnosis of tyrosine hydroxylase deficiency. Prenat Diagn 25:671675.
  • Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L. 2006. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314:19301933.
  • Nagatsu T, Levitt M, Udenfriend S. 1964. Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem 239:29102917.
  • Nutt DJ. 2006. The role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry 67(Suppl 6):38.
  • Ozbay F, Wigg KG, Turanli ET, Asherson P, Yazgan Y, Sandor P, Barr CL. 2006. Analysis of the dopamine beta hydroxylase gene in Gilles de la Tourette syndrome. Am J Med Genet B Neuropsychiatr Genet 141:673677.
  • Park JK, Kim JW, Lee HJ, Chung JH, Ha EY, Oh DJ, Song JY. 2007. Dopamine beta-hydroxylase gene polymorphisms and psychotic symptoms in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 144:944945.
  • Peters WR, MacMurry JP, Walker J, Giese RJ Jr, Comings DE. 2003. Phenylethanolamine N-methyltransferase G-148A genetic variant and weight loss in obese women. Obes Res 11:415419.
  • Pons R, Ford B, Chiriboga CA, Clayton PT, Hinton V, Hyland K, Sharma R, De Vivo DC. 2004. Aromatic l-amino acid decarboxylase deficiency: clinical features, treatment, and prognosis. Neurology 62:10581065.
  • Quaife CJ, Hoyle GW, Froelick GJ, Findley SD, Baetge EE, Behringer RR, Hammang JP, Brinster RL, Palmiter RD. 1994. Visualization and ablation of phenylethanolamine N-methyltransferase producing cells in transgenic mice. Transgenic Res 3:388400.
  • Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM. 1997. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239:298304.
  • Ramaekers VT, Senderek J, Hausler M, Haring M, Abeling N, Zerres K, Bergmann C, Heimann G, Blau N. 2001. A novel neurodevelopmental syndrome responsive to 5-hydroxytryptophan and carbidopa. Mol Genet Metab 73:179187.
  • Ribases M, Serrano M, Fernandez-Alvarez E, Pahisa S, Ormazabal A, Garcia-Cazorla A, Perez-Duenas B, Campistol J, Artuch R, Cormand B. 2007. A homozygous tyrosine hydroxylase gene promoter mutation in a patient with dopa-responsive encephalopathy: clinical, biochemical and genetic analysis. Mol Genet Metab 92:274277.
  • Ribases M, Ramos-Quiroga JA, Hervás A, Bosch R, Bielsa A, Gastaminza X, Artigas J, Rodriguez-Ben S, Estivill X, Casas M, Cormand B, Bayés M. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol Psychiatry (in press). [Epub ahead of print].
  • Rosenberg S, Templeton AR, Feigin PD, Lancet D, Beckmann JS, Selig S, Hamer DH, Skorecki K. 2006. The association of DNA sequence variation at the MAOA genetic locus with quantitative behavioural traits in normal males. Hum Genet 120:447459.
  • Royo M, Daubner SC, Fitzpatrick PF. 2005. Effects of mutations in tyrosine hydroxylase associated with progressive dystonia on the activity and stability of the protein. Proteins 58:1421.
  • Savitz J, Solms M, Ramesar R. 2006. The molecular genetics of cognition: dopamine, COMT and BDNF. Genes Brain Behav 5:311328.
  • Scheuch K, Lautenschlager M, Grohmann M, Stahlberg S, Kirchheiner J, Zill P, Heinz A, Walther DJ, Priller J. 2007. Characterization of a functional promoter polymorphism of the human tryptophan hydroxylase 2 gene in serotonergic raphe neurons. Biol Psychiatry 62:12881294.
  • Schiller A, Wevers RA, Steenbergen GC, Blau N, Jung HH. 2004. Long-term course of l-dopa-responsive dystonia caused by tyrosine hydroxylase deficiency. Neurology 63:15241526.
  • Senard JM, Rouet P. 2006. Dopamine beta-hydroxylase deficiency. Orphanet J Rare Dis 1:7.
  • Shih JC, Thompson RF. 1999. Monoamine oxidase in neuropsychiatry and behavior. Am J Hum Genet 65:593598.
  • Shih JC, Chen K, Ridd MJ. 1999. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197217.
  • Shih JC. 2004. Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B. Neurotoxicology 25:2130.
  • Sumi-Ichinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T. 1992. Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic l-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry 31:22292238.
  • Swaans RJ, Rondot P, Renier WO, Van Den Heuvel LP, Steenbergen-Spanjers GC, Wevers RA. 2000. Four novel mutations in the tyrosine hydroxylase gene in patients with infantile parkinsonism. Ann Hum Genet 64(Pt 1):2531.
  • Swoboda KJ, Saul JP, McKenna CE, Speller NB, Hyland K. 2003. Aromatic l-amino acid decarboxylase deficiency: overview of clinical features and outcomes. Ann Neurol 54(Suppl 6):S49S55.
  • Tay SK, Poh KS, Hyland K, Pang YW, Ong HT, Low PS, Goh DL. 2007. Unusually mild phenotype of AADC deficiency in 2 siblings. Mol Genet Metab 91:374378.
  • Thomae BA, Rifki OF, Theobald MA, Eckloff BW, Wieben ED, Weinshilboum RM. 2003. Human catecholamine sulfotransferase (SULT1A3) pharmacogenetics: functional genetic polymorphism. J Neurochem 87:809819.
  • Thony B, Blau N. 2006. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Hum Mutat 27:870878.
  • Thöny B, Gibson KM. 2006. Murine models of inherited monoaminergic and GABAergic neurotransmitter disorders. Future Neurol 1:665676.
  • Van Den Bogaert A, Sleegers K, De Zutter S, Heyrman L, Norrback KF, Adolfsson R, Van Broeckhoven C, Del-Favero J. 2006. Association of brain-specific tryptophan hydroxylase, TPH2, with unipolar and bipolar disorder in a Northern Swedish, isolated population. Arch Gen Psychiatry 63:11031110.
  • van den Heuvel LP, Luiten B, Smeitink JA, de Rijk-van Andel JF, Hyland K, Steenbergen-Spanjers GC, Janssen RJ, Wevers RA. 1998. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive l-DOPA-responsive dystonia in the Dutch population. Hum Genet 102:644646.
  • Verbeek MM, Geurtz PB, Willemsen MA, Wevers RA. 2007a. Aromatic l-amino acid decarboxylase enzyme activity in deficient patients and heterozygotes. Mol Genet Metab 90:363369.
  • Verbeek MM, Steenbergen-Spanjers GC, Willemsen MA, Hol FA, Smeitink J, Seeger J, Grattan-Smith P, Ryan MM, Hoffmann GF, Donati MA, Blau N, Wevers RA. 2007b. Mutations in the cyclic adenosine monophosphate response element of the tyrosine hydroxylase gene. Ann Neurol 62:422426.
  • Walther DJ, Bader M. 2003. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 66:16731680.
  • Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, Bader M. 2003. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 299:76.
  • Waters PJ. 2003. How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression. Hum Mutat 21:357369.
  • Wevers RA, de Rijk-van Andel JF, Brautigam C, Geurtz B, van den Heuvel LP, Steenbergen-Spanjers GC, Smeitink JA, Hoffmann GF, Gabreels FJ. 1999. A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC). J Inherit Metab Dis 22:364373.
  • Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PEM. 2008. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation. Hum Mutat 29:613.
  • Winge I, McKinney JA, Knappskog PM, Haavik J. 2007. Characterization of wild-type and mutant forms of human tryptophan hydroxylase 2. J Neurochem 100:16481657.
  • Wong DL, Tai TC, Wong-Faull DC, Claycomb R, Kvetnansky R. 2004. Genetic mechanisms for adrenergic control during stress. Ann NY Acad Sci 1018:387397.
  • Wu YH, Fischer DF, Swaab DF. 2007. A promoter polymorphism in the monoamine oxidase A gene is associated with the pineal MAOA activity in Alzheimer's disease patients. Brain Res 1167:1319.
  • Zhang X, Gainetdinov RR, Beaulieu JM, Sotnikova TD, Burch LH, Williams RB, Schwartz DA, Krishnan KR, Caron MG. 2005. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45:1116.
  • Zhang H, Ye Y, Wang X, Gelernter J, Ma JZ, Li MD. 2006a. DOPA decarboxylase gene is associated with nicotine dependence. Pharmacogenomics 7:11591166.
  • Zhang X, Beaulieu JM, Gainetdinov RR, Caron MG. 2006b. Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2. Cell Mol Life Sci 63:611.
  • Zhou Z, Peters EJ, Hamilton SP, McMahon F, Thomas C, McGrath PJ, Rush J, Trivedi MH, Charney DS, Roy A, Wisniewski S, Lipsky R, Goldman D. 2005a. Response to Zhang et al. ([126]2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11–16. Neuron 48:702703; author reply 705–706.
  • Zhou Z, Roy A, Lipsky R, Kuchipudi K, Zhu G, Taubman J, Enoch MA, Virkkunen M, Goldman D. 2005b. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry 62:11091118.
  • Ziegler MG, Bao X, Kennedy BP, Joyner A, Enns R. 2002. Location, development, control, and function of extraadrenal phenylethanolamine N-methyltransferase. Ann NY Acad Sci 971:7682.